PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis [...]
ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy [...]
Soft tissue tumor with adipocytic differentiation
Soft tissue tumor with adipocytic differentiation Annales de pathologie, [...]
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 [...]
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 [...]
Targeting epigenetics in sarcomas through EZH2 inhibition
Targeting epigenetics in sarcomas through EZH2 inhibition Journal of [...]
Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)
Incidence and time trends of sarcoma (2000-2013): results from [...]
IDO Targeting in Sarcoma: Biological and Clinical Implications
IDO Targeting in Sarcoma: Biological and Clinical Implications Frontiers [...]
LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications [...]
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma [...]